Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhengchang He
HO-1 Promotes Resistance to an EZH2 Inhibitor Through the pRB-E2F Pathway: Correlation With the Progression of Myelodysplastic Syndrome Into Acute Myeloid Leukemia
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Effect of BCLAF1 on HDAC Inhibitor LMK-235-mediated Apoptosis of Diffuse Large B Cell Lymphoma Cells and Its Mechanism
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Related publications
Inositide-Specific Phospholipase C Β1 Gene Deletion in the Progression of Myelodysplastic Syndrome to Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Dual Roles of EZH2 in Acute Myeloid Leukemia
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Activation of FGFR1β Signaling Pathway Promotes Survival, Migration and Resistance to Chemotherapy in Acute Myeloid Leukemia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia Associated With Complete or Partial Monosomy 7
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Inhibition of EZH2 Degradation as a Novel Approach to Overcome Drug Resistance in Acute Myeloid Leukemia
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Heterogeneous Patterns of CEBP Mutation Status in the Progression of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia to Acute Myelogenous Leukemia
Clinical Cancer Research
Cancer Research
Oncology
IRF9 Inhibits Human Acute Myeloid Leukemia Through the SIRT1-p53 Signaling Pathway
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
Identification of Target Genes of the P16INK4A-pRB-E2f Pathway
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology